M..you know that's intellectual dishonesty. Roche valued INO at 400+ million market cap and that is around 2 bux a share with the current OS. We are right where we are supposed to be, a valuation only based on a small position of INO's product line. Please, stop disrespecting your own intelligence just for a buck. It is really disheartening. I have enjoyed reading your work here up until now, I hope that changes.
Market Data 
Markets 
AI
